0305 ECP Araris
BioCentury & Getty Images

Emerging Company Profile

Araris: universal linkers for antibody-drug conjugates

Emerging Company Profile: Swiss newco is developing peptide linkers that could improve ADC’s therapeutic window

Swiss start-up Araris is developing peptide linkers that could improve the therapeutic window and manufacturing of antibody-drug conjugates. 

Mar 6, 2021 | 2:11 AM GMT

Araris is developing antibody-drug conjugate linker technology that could widen the therapeutic

Read the full 635 word article

How to gain access

Continue reading with a
two-week free trial.